Christopher Kirk
2018
In 2018, Christopher Kirk earned a total compensation of $962.4K as President and Chief Scientific Officer at Kezar Life Sciences, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $137,970 |
|---|---|
| Option Awards | $447,782 |
| Salary | $365,000 |
| Other | $11,601 |
| Total | $962,353 |
Kirk received $447.8K in option awards, accounting for 47% of the total pay in 2018.
Kirk also received $138K in non-equity incentive plan, $365K in salary and $11.6K in other compensation.
Rankings
In 2018, Christopher Kirk's compensation ranked 9,380th out of 14,244 executives tracked by ExecPay. In other words, Kirk earned more than 34.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,380 out of 14,244 | 34th |
Division Manufacturing | 3,760 out of 5,765 | 35th |
Major group Chemicals And Allied Products | 1,416 out of 2,128 | 34th |
Industry group Drugs | 1,192 out of 1,817 | 34th |
Industry Pharmaceutical Preparations | 922 out of 1,391 | 34th |
Source: SEC filing on April 30, 2019.
Kirk's colleagues
We found two more compensation records of executives who worked with Christopher Kirk at Kezar Life Sciences in 2018.